DOCU vs STRO
DocuSign Inc (DOCU) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the DOCU and STRO stock pages for the full models.
Not investment advice.